Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2026-02-01 @ 1:05 AM
Study NCT ID:
NCT05033769
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2020-06-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer
Sponsor:
Organization: